[HTML][HTML] In vitro models of medulloblastoma: Choosing the right tool for the job
The recently-defined four molecular subgroups of medulloblastoma have required updating
of our understanding of in vitro models to include molecular classification and risk …
of our understanding of in vitro models to include molecular classification and risk …
GABAergic signaling beyond synapses: an emerging target for cancer therapy
Traditionally, γ-aminobutyric acid (GABA) is best known for its role as a primary inhibitory
neurotransmitter reducing neuronal excitability in the mammalian central nervous system …
neurotransmitter reducing neuronal excitability in the mammalian central nervous system …
[HTML][HTML] GABAergic signaling as a potential therapeutic target in cancers
Y Yang, L Ren, W Li, Y Zhang, S Zhang, B Ge… - Biomedicine & …, 2023 - Elsevier
GABA is the most common inhibitory neurotransmitter in the vertebrate central nervous
system. Synthesized by glutamic acid decarboxylase, GABA could specifically bind with two …
system. Synthesized by glutamic acid decarboxylase, GABA could specifically bind with two …
[HTML][HTML] Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination
Medulloblastoma (MB) is a malignant pediatric brain tumor arising in the cerebellum.
Although abnormal GABAergic receptor activation has been described in MB, studies have …
Although abnormal GABAergic receptor activation has been described in MB, studies have …
Neuronal activity in ontogeny and oncology
H Venkatesh, M Monje - Trends in cancer, 2017 - cell.com
The nervous system plays a central role in regulating the stem cell niche in many organs,
and thereby pivotally modulates development, homeostasis, and plasticity. A similarly …
and thereby pivotally modulates development, homeostasis, and plasticity. A similarly …
[HTML][HTML] Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas
O Menyhárt, F Giangaspero, B Győrffy - Journal of Hematology & Oncology, 2019 - Springer
Childhood medulloblastomas (MB) are heterogeneous and are divided into four molecular
subgroups. The provisional non-wingless-activated (WNT)/non-sonic hedgehog-activated …
subgroups. The provisional non-wingless-activated (WNT)/non-sonic hedgehog-activated …
[HTML][HTML] The neurodevelopmental and molecular landscape of medulloblastoma subgroups: Current targets and the potential for combined therapies
Simple Summary Medulloblastoma is the most common malignant brain tumor in the
pediatric population. Despite the utilization of aggressive treatment modalities, including …
pediatric population. Despite the utilization of aggressive treatment modalities, including …
Therapeutically leveraging GABAA receptors in cancer
D Bhattacharya, VS Gawali, L Kallay… - Experimental …, 2021 - journals.sagepub.com
γ-aminobutyric acid or GABA is an amino acid that functionally acts as a neurotransmitter
and is critical to neurotransmission. GABA is also a metabolite in the Krebs cycle. It is …
and is critical to neurotransmission. GABA is also a metabolite in the Krebs cycle. It is …
[HTML][HTML] HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway
F Xiong, W Liu, X Wang, G Wu, Q Wang, T Guo… - Cell Death & …, 2022 - nature.com
Abstract Homeobox A5 (HOXA5) is a transcription factor in mammalian and can regulate cell
differentiation, proliferation, and apoptosis as well as tumorigenesis. However, little is known …
differentiation, proliferation, and apoptosis as well as tumorigenesis. However, little is known …
Malignancies in prader-willi syndrome: results from a large international cohort and literature review
K Pellikaan, NQC Nguyen… - The Journal of …, 2023 - academic.oup.com
Abstract Context Prader-Willi syndrome (PWS) is a complex disorder combining
hypothalamic dysfunction, neurodevelopmental delay, hypotonia, and hyperphagia with risk …
hypothalamic dysfunction, neurodevelopmental delay, hypotonia, and hyperphagia with risk …